L. C. Dogolo - Concepedia

Author

L. C. Dogolo

Pfizer (United States)

Also Known As

L C Dogolo, L. C. Dogolo, L. Dogolo, Lisa C. Dogolo, Lisa Dogolo

Publications

274

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)The University of Texas Health Science Center at San Antonio

About

L. C. Dogolo is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	198
2	Anesthesia	1	1	30
3	Biochemistry	1	1	32
4	Gastroenterology	1	1	11
5	Hepatology	1	1	14

L. C. Dogolo

Publications

266

Citations

H-Index

Page 1

	Year	Citations
Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine John Vincent, Stuart Harris, George Foulds, British Journal of Clinical Pharmacology	2000	68
Oral bioavailability of trovafloxacin with and without food in healthy volunteers Rongyue Teng, L. C. Dogolo, Susan Willavize, Journal of Antimicrobial Chemotherapy NutritionPharmaceutical ScienceOral BioavailabilityPharmacological StudyHealthy Volunteers	1997	51
Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers John Vincent, Rongyue Teng, L. C. Dogolo, Journal of Antimicrobial Chemotherapy Antimicrobial SusceptibilityHealthy SubjectsAntibioticsHealthy VolunteersMean Cmax	1997	38
Effect of Maalox and omeprazole on the bioavailability of trovafloxacin Rongyue Teng, L. C. Dogolo, Susan Willavize, Journal of Antimicrobial Chemotherapy Pharmaceutical SciencePharmacological StudyBiochemistryHealthy Male VolunteersPharmacology	1997	32
Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin N.R. Cutler, Jean‐Louis Vincent, S. S. Jhee, Antimicrobial Agents and Chemotherapy Intravenous InfusionTwelve Healthy SubjectsHealthy SubjectsMedicineCerebrospinal Fluid	1997	30
Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans John Vincent, L. C. Dogolo, B. Baris, European Journal of Clinical Microbiology & Infectious Diseases Pharmacological StudyMultiple-dose AdministrationPharmacologyClinical PharmacologyPharmacotherapy	1998	22
Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers George Melnik, Wayne H. Schwesinger, Rongyue Teng, European Journal of Clinical Microbiology & Infectious Diseases HepatologyMedicineLiver PhysiologyHealthy VolunteersHepatotoxicity	1998	14
Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery George Melnik, Wayne H. Schwesinger, L. C. Dogolo, The American Journal of Surgery Intravenous InfusionGastrointestinal PharmacologyColorectal SurgeryMedicineGastroenterology	1998	11

Page 1